Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | arachidonate 15-lipoxygenase | Starlite/ChEMBL | No references |
Homo sapiens | bromodomain adjacent to zinc finger domain, 2B | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | parathyroid hormone 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | arachidonate 5 lipoxygenase | arachidonate 15-lipoxygenase | 662 aa | 590 aa | 23.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0081 | 0.0081 |
Brugia malayi | Cytochrome P450 family protein | 0.0051 | 0.1493 | 0.1493 |
Brugia malayi | Ets-domain containing protein | 0.007 | 0.2513 | 0.2513 |
Schistosoma mansoni | rab6-interacting | 0.0024 | 0.0081 | 0.0009 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0025 | 0.0139 | 0.0139 |
Echinococcus multilocularis | Polycystic kidney disease protein | 0.0024 | 0.0081 | 0.0035 |
Schistosoma mansoni | bromodomain containing protein | 0.0076 | 0.2832 | 0.278 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0988 | 0.0922 |
Onchocerca volvulus | 0.0024 | 0.0081 | 0.5 | |
Schistosoma mansoni | hypothetical protein | 0.0024 | 0.0081 | 0.0009 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.1108 | 0.5 |
Schistosoma mansoni | lipoxygenase | 0.0067 | 0.2322 | 0.2266 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.1108 | 0.1043 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0081 | 0.0081 |
Plasmodium vivax | multidomain scavenger receptor, putative | 0.0024 | 0.0081 | 0.5 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0043 | 0.1105 | 0.4076 |
Leishmania major | cytochrome p450-like protein | 0.0022 | 0 | 0.5 |
Brugia malayi | hypothetical protein | 0.0043 | 0.1108 | 0.1108 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0051 | 0.1493 | 0.1493 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.1108 | 0.4088 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0022 | 0 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0022 | 0 | 0.5 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0022 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.3302 | 0.3302 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.1984 | 0.1984 |
Brugia malayi | hypothetical protein | 0.0024 | 0.0081 | 0.0081 |
Trypanosoma brucei | cytochrome P450, putative | 0.0022 | 0 | 0.5 |
Echinococcus granulosus | GA binding protein alpha chain | 0.007 | 0.2513 | 0.9634 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.0024 | 0.0081 | 0.0035 |
Schistosoma mansoni | gabp alpha | 0.007 | 0.2513 | 0.2459 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.198 | 0.198 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0027 | 0.026 | 0.0739 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.0024 | 0.0081 | 0.0035 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0024 | 0.0081 | 0.5 |
Echinococcus granulosus | RUN | 0.0024 | 0.0081 | 0.0035 |
Brugia malayi | Ets-domain containing protein | 0.007 | 0.2513 | 0.2513 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.1108 | 0.1043 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.1108 | 0.4088 |
Brugia malayi | Doublecortin family protein | 0.0024 | 0.0081 | 0.0081 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.0024 | 0.0081 | 0.0035 |
Schistosoma mansoni | hypothetical protein | 0.0025 | 0.0139 | 0.0067 |
Echinococcus granulosus | Polycystic kidney disease protein | 0.0024 | 0.0081 | 0.0035 |
Brugia malayi | PHD-finger family protein | 0.003 | 0.0409 | 0.0409 |
Echinococcus multilocularis | GA binding protein alpha chain | 0.007 | 0.2513 | 0.9634 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.1409 | 0.1409 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.1108 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.1108 | 0.5 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0067 | 0.2322 | 0.888 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.1984 | 0.1984 |
Loa Loa (eye worm) | doublecortin family protein | 0.0024 | 0.0081 | 0.0081 |
Onchocerca volvulus | 0.0024 | 0.0081 | 0.5 | |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.1984 | 0.1984 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.1259 | 0.1259 |
Schistosoma mansoni | lipoxygenase | 0.0024 | 0.0081 | 0.0009 |
Brugia malayi | Bromodomain containing protein | 0.0046 | 0.1255 | 0.1255 |
Schistosoma mansoni | loxhd1 | 0.0024 | 0.0081 | 0.0009 |
Schistosoma mansoni | ets-related | 0.0213 | 1 | 1 |
Schistosoma mansoni | rab6-interacting | 0.0024 | 0.0081 | 0.0009 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0043 | 0.1105 | 0.4076 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0072 | 0.2606 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0988 | 0.0988 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.1529 | 0.1529 |
Echinococcus multilocularis | RUN | 0.0024 | 0.0081 | 0.0035 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.0024 | 0.0081 | 0.0035 |
Brugia malayi | Bromodomain containing protein | 0.0091 | 0.3572 | 0.3572 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0072 | 0.2606 | 1 |
Loa Loa (eye worm) | fli-1 protein | 0.0213 | 1 | 1 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0027 | 0.026 | 0.0739 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0988 | 0.0988 |
Brugia malayi | hypothetical protein | 0.0024 | 0.0081 | 0.0081 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.1984 | 0.1984 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0027 | 0.026 | 0.0189 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.1108 | 0.5 |
Loa Loa (eye worm) | D-ets-4 DNA binding domain-containing protein | 0.007 | 0.2513 | 0.2513 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0067 | 0.2322 | 0.888 |
Schistosoma mansoni | polycystin 1-related | 0.0024 | 0.0081 | 0.0009 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.7079 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 6.3096 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 9.2 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.